Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3640796
Max Phase: Preclinical
Molecular Formula: C16H27N3O2
Molecular Weight: 293.41
Molecule Type: Small molecule
Associated Items:
ID: ALA3640796
Max Phase: Preclinical
Molecular Formula: C16H27N3O2
Molecular Weight: 293.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NCCCC(Cc1cn(C2CCCCCC2)cn1)C(=O)O
Standard InChI: InChI=1S/C16H27N3O2/c17-9-5-6-13(16(20)21)10-14-11-19(12-18-14)15-7-3-1-2-4-8-15/h11-13,15H,1-10,17H2,(H,20,21)
Standard InChI Key: MHKMIQNCAHVRCX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 293.41 | Molecular Weight (Monoisotopic): 293.2103 | AlogP: 2.76 | #Rotatable Bonds: 7 |
Polar Surface Area: 81.14 | Molecular Species: ZWITTERION | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 4.06 | CX Basic pKa: 10.21 | CX LogP: -0.10 | CX LogD: -0.12 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.76 | Np Likeness Score: 0.03 |
1. (2013) Cycloalkyl-substituted imidazole derivative, |
Source(1):